精准治疗肥胖。

Lizeth Cifuentes, Maria Daniela Hurtado A, Jeanette Eckel-Passow, Andres Acosta
{"title":"精准治疗肥胖。","authors":"Lizeth Cifuentes,&nbsp;Maria Daniela Hurtado A,&nbsp;Jeanette Eckel-Passow,&nbsp;Andres Acosta","doi":"10.1055/s-0041-1729945","DOIUrl":null,"url":null,"abstract":"<p><p>Obesity is a multifactorial disease with a variable and underwhelming weight loss response to current treatment approaches. Precision medicine proposes a new paradigm to improve disease classification based on the premise of human heterogeneity, with the ultimate goal of maximizing treatment effectiveness, tolerability, and safety. Recent advances in high-throughput biochemical assays have contributed to the partial characterization of obesity's pathophysiology, as well as to the understanding of the role that intrinsic and environmental factors, and their interaction, play in its development and progression. These data have led to the development of biological markers that either are being or will be incorporated into strategies to develop personalized lines of treatment for obesity. There are currently many ongoing initiatives aimed at this; however, much needs to be resolved before precision obesity medicine becomes common practice. This review aims to provide a perspective on the currently available data of high-throughput technologies to treat obesity.</p>","PeriodicalId":91014,"journal":{"name":"Digestive disease interventions","volume":"5 3","pages":"239-248"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-0041-1729945","citationCount":"8","resultStr":"{\"title\":\"Precision Medicine for Obesity.\",\"authors\":\"Lizeth Cifuentes,&nbsp;Maria Daniela Hurtado A,&nbsp;Jeanette Eckel-Passow,&nbsp;Andres Acosta\",\"doi\":\"10.1055/s-0041-1729945\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Obesity is a multifactorial disease with a variable and underwhelming weight loss response to current treatment approaches. Precision medicine proposes a new paradigm to improve disease classification based on the premise of human heterogeneity, with the ultimate goal of maximizing treatment effectiveness, tolerability, and safety. Recent advances in high-throughput biochemical assays have contributed to the partial characterization of obesity's pathophysiology, as well as to the understanding of the role that intrinsic and environmental factors, and their interaction, play in its development and progression. These data have led to the development of biological markers that either are being or will be incorporated into strategies to develop personalized lines of treatment for obesity. There are currently many ongoing initiatives aimed at this; however, much needs to be resolved before precision obesity medicine becomes common practice. This review aims to provide a perspective on the currently available data of high-throughput technologies to treat obesity.</p>\",\"PeriodicalId\":91014,\"journal\":{\"name\":\"Digestive disease interventions\",\"volume\":\"5 3\",\"pages\":\"239-248\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1055/s-0041-1729945\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Digestive disease interventions\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0041-1729945\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Digestive disease interventions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0041-1729945","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

摘要

肥胖是一种多因素疾病,对目前的治疗方法有一个可变的和不引人注目的减肥反应。精准医学在人类异质性的前提下,提出了一种改进疾病分类的新范式,其最终目标是实现治疗效果、耐受性和安全性的最大化。高通量生化分析的最新进展有助于部分表征肥胖的病理生理,以及对内在因素和环境因素及其相互作用在其发展和进展中的作用的理解。这些数据导致了生物标记物的发展,这些生物标记物正在或将被纳入开发个性化肥胖治疗方案的策略中。目前有许多正在进行的倡议旨在实现这一目标;然而,在精准肥胖药物成为普遍做法之前,还有很多问题需要解决。本综述旨在对目前高通量技术治疗肥胖的数据提供一个视角。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Precision Medicine for Obesity.

Obesity is a multifactorial disease with a variable and underwhelming weight loss response to current treatment approaches. Precision medicine proposes a new paradigm to improve disease classification based on the premise of human heterogeneity, with the ultimate goal of maximizing treatment effectiveness, tolerability, and safety. Recent advances in high-throughput biochemical assays have contributed to the partial characterization of obesity's pathophysiology, as well as to the understanding of the role that intrinsic and environmental factors, and their interaction, play in its development and progression. These data have led to the development of biological markers that either are being or will be incorporated into strategies to develop personalized lines of treatment for obesity. There are currently many ongoing initiatives aimed at this; however, much needs to be resolved before precision obesity medicine becomes common practice. This review aims to provide a perspective on the currently available data of high-throughput technologies to treat obesity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信